Respiratory Muscle Fatigue at Different Breathing Modes
Primary Purpose
Healthy
Status
Recruiting
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Square wave breathing
Sponsored by

About this trial
This is an interventional basic science trial for Healthy
Eligibility Criteria
Inclusion Criteria:
- Healthy men or women
- Age ≥18 and ≤60 years
- BMI ≥ 20 and ≤30
Exclusion Criteria:
- Drug addiction defined as the use of cannabis, opioids or other drugs
- Previous and present neurologic (e.g. ataxia), musculoskeletal (e.g. muscular dystrophy) or mental illnesses (e.g. schizophrenia)
- History of mechanical ventilation, COVID-19 with respiratory complications, lung cancer
- Part of lung resected
- Presence of dyspepsia/heart-burn/abdominal pain
- Presence of esophageal varices
- Presence of liver disease
- Presence of esophageal hernia
- Pregnancy
- Failure to comply with transcranial magnetic stimulation adult safety screen
- History of epilepsy, metal implants in head or jaw
- Acute or chronic lung diseases, e.g. asthma, COPD, bronchitis etc.
- Lack of ability to cooperate
Sites / Locations
- Mathias Krogh PoulsenRecruiting
Outcomes
Primary Outcome Measures
Time to task failure (Tlim)
The time (s) from the subject starts to breathe under the experimental condition, and until task failure will be measured. Task failure is defied by either subject intolerance to continue or by lacking ability of the subject to maintain the target pressure and/or timing. From a previous publication (Bellemare and Grassino, JAP, 1982), it is estimated that subjects will reach Tlim between 30min to 1 hour. If breathing is continued after 1 hour, task failure will not happen as breathing can be continued indefinitely.
Secondary Outcome Measures
Respiratory muscle pressures
Respiratory muscle pressure will be measured by esophageal and gastric pressure (in cmH2O) using a naso gastric catheter fitted with double balloons (Nutrivent) connected to a pressure sensor (ICU lab, KleisTek).
Tidal volume
Tidal Volume (ml) will be measured with a flowsensor (Hans Rudolph) through a pressure box (ICU lab, KleisTek)
Respiratory work
Work of breathing (j), will be calculated from outcome measure 2 and 9 (pressure (cmH2O) and insp. and expiratory time (s)). Measured with pressure box (ICU lab, KleisTek)
Ratings of perceived exertion
Borg Dyspnea Scale, from 0-10 where 0 is no effort at all and 10 is maximal breathing effort.
Metabolism
Energy expenditure calculated from VO2 (ml/min) nad VCO2 (ml/min) with e.g Weir equation. VO2 and VCO2 are measured with Beacon (Mermaid care).
Respiratory rate
Respiratory rate (breaths/min) will be measured with a flowsensor (Hans Rudolph) through a pressure box (ICU lab, KleisTek)
Minute ventilation
Minyte ventilation (l/min) will be measured with a flowsensor (Hans Rudolph) through a pressure box (ICU lab, KleisTek)
Insp. and expiratory time
Insp. and expiratory time (s) will be measured with a flowsensor (Hans Rudolph) through a pressure box (ICU lab, KleisTek)
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05393115
Brief Title
Respiratory Muscle Fatigue at Different Breathing Modes
Official Title
Does Inspiratory Pressure Wave Form Influence Respiratory Muscle Fatigue and Metabolism During Resistive Breathing
Study Type
Interventional
2. Study Status
Record Verification Date
May 2022
Overall Recruitment Status
Recruiting
Study Start Date
October 1, 2021 (Actual)
Primary Completion Date
December 1, 2022 (Anticipated)
Study Completion Date
December 1, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Aalborg University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The study aims at investigating if time to respiratory muscle fatigue and metabolism are influenced by the pressure wave form mode applied during resistive breathing.
Detailed Description
In healthy subjects fitted with a nasogastric double balloon catheter and breathing at a resistance, the investigators will measure time to failure, Borg ratings, VO2, VCO2, flow, esophageal-, gastric- and airway-pressure. This will be done during breathing at either a square wave or triangle wave pressure waveform, in random order and trials separated by >two days. Further respiratory muscle fatigue will be investigated pre and post intervention by maximal esophageal pressure generation (voluntary and with cervical magnetic stimulation).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Healthy
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Participant
Allocation
Randomized
Enrollment
12 (Anticipated)
8. Arms, Groups, and Interventions
Intervention Type
Other
Intervention Name(s)
Square wave breathing
Other Intervention Name(s)
Triangle wave breathing
Intervention Description
difference in time to failure from the two breathing modes
Primary Outcome Measure Information:
Title
Time to task failure (Tlim)
Description
The time (s) from the subject starts to breathe under the experimental condition, and until task failure will be measured. Task failure is defied by either subject intolerance to continue or by lacking ability of the subject to maintain the target pressure and/or timing. From a previous publication (Bellemare and Grassino, JAP, 1982), it is estimated that subjects will reach Tlim between 30min to 1 hour. If breathing is continued after 1 hour, task failure will not happen as breathing can be continued indefinitely.
Time Frame
Up to two months between the two different breathing trials (randomized order)
Secondary Outcome Measure Information:
Title
Respiratory muscle pressures
Description
Respiratory muscle pressure will be measured by esophageal and gastric pressure (in cmH2O) using a naso gastric catheter fitted with double balloons (Nutrivent) connected to a pressure sensor (ICU lab, KleisTek).
Time Frame
Up to two months between the two different breathing trials (randomized order)
Title
Tidal volume
Description
Tidal Volume (ml) will be measured with a flowsensor (Hans Rudolph) through a pressure box (ICU lab, KleisTek)
Time Frame
Up to two months between the two different breathing trials (randomized order)
Title
Respiratory work
Description
Work of breathing (j), will be calculated from outcome measure 2 and 9 (pressure (cmH2O) and insp. and expiratory time (s)). Measured with pressure box (ICU lab, KleisTek)
Time Frame
Up to two months between the two different breathing trials (randomized order)
Title
Ratings of perceived exertion
Description
Borg Dyspnea Scale, from 0-10 where 0 is no effort at all and 10 is maximal breathing effort.
Time Frame
Up to two months between the two different breathing trials (randomized order)
Title
Metabolism
Description
Energy expenditure calculated from VO2 (ml/min) nad VCO2 (ml/min) with e.g Weir equation. VO2 and VCO2 are measured with Beacon (Mermaid care).
Time Frame
Up to two months between the two different breathing trials (randomized order)
Title
Respiratory rate
Description
Respiratory rate (breaths/min) will be measured with a flowsensor (Hans Rudolph) through a pressure box (ICU lab, KleisTek)
Time Frame
Up to two months between the two different breathing trials (randomized order)
Title
Minute ventilation
Description
Minyte ventilation (l/min) will be measured with a flowsensor (Hans Rudolph) through a pressure box (ICU lab, KleisTek)
Time Frame
Up to two months between the two different breathing trials (randomized order)
Title
Insp. and expiratory time
Description
Insp. and expiratory time (s) will be measured with a flowsensor (Hans Rudolph) through a pressure box (ICU lab, KleisTek)
Time Frame
Up to two months between the two different breathing trials (randomized order)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Healthy men or women
Age ≥18 and ≤60 years
BMI ≥ 20 and ≤30
Exclusion Criteria:
Drug addiction defined as the use of cannabis, opioids or other drugs
Previous and present neurologic (e.g. ataxia), musculoskeletal (e.g. muscular dystrophy) or mental illnesses (e.g. schizophrenia)
History of mechanical ventilation, COVID-19 with respiratory complications, lung cancer
Part of lung resected
Presence of dyspepsia/heart-burn/abdominal pain
Presence of esophageal varices
Presence of liver disease
Presence of esophageal hernia
Pregnancy
Failure to comply with transcranial magnetic stimulation adult safety screen
History of epilepsy, metal implants in head or jaw
Acute or chronic lung diseases, e.g. asthma, COPD, bronchitis etc.
Lack of ability to cooperate
Facility Information:
Facility Name
Mathias Krogh Poulsen
City
Aalborg
State/Province
Danmark
ZIP/Postal Code
9220
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mathias K Poulsen
Phone
28297625
Ext
0045
Email
mkpo@hst.aau.dk
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Respiratory Muscle Fatigue at Different Breathing Modes
We'll reach out to this number within 24 hrs